{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:11:35Z","timestamp":1786983095183,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Objective<\/jats:title>\n                    <jats:p>Transfusion-transmitted infectious agents are amongst the major health burden worldwide. The purpose of this study was to evaluate the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) among blood donors in Samtah General Hospital, Jazan region, Saudi Arabia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods<\/jats:title>\n                    <jats:p>In this retrospective study, blood donation records of all blood donors recruited between January 2019 and August 2020 were included for data acquisition. A total of 4977 blood donors\u2019 records were reviewed and data were analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Hepatitis B profile showed 0.60% blood donors positive for hepatis B surface antigen (HBsAg). Nucleic acid testing (NAT) showed the presence of HBV-DNA in 0.4% of the blood donors. Anti-HBs and anti-HBc antibodies were reactive in 3.34% and 7.31% blood donors\u2019 units, respectively. Anti-HCV antibodies were reactive among 54 (1.09%) blood donors. Upon reviewing the NAT analysis results, 0.16% (08) blood donors showed the presence of HCV-RNA in their blood units. Anti-HIV antibodies were reactive in 8 (0.16%) blood donors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>It is concluded that the frequency of HBsAg is comparatively lower while anti-HCV positivity is higher in Samtah, Jazan as a region compared to other regions of the country. Further studies are warranted to evaluate the cause of HCV infection in this area. Frequency of HIV is uncommon in this area.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s44197-022-00051-7","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T09:03:28Z","timestamp":1659171808000},"page":"304-310","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Patterns of Hepatitis B, Hepatitis C and HIV Among Blood Donors in Samtah-Jazan Region"],"prefix":"10.1007","volume":"12","author":[{"given":"Abdullah A.","family":"Mobarki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maymoon M.","family":"Madkhali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gasim","family":"Dobie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Saboor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aymen M.","family":"Madkhali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basem","family":"Madkhli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahia","family":"Hummadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Meshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham M.","family":"Al-Mekhlafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad S.","family":"Akhter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan A.","family":"Hamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"key":"51_CR1","unstructured":"WHO. Progress report on HIV, viral hepatitis and sexually transmitted infections, vol 53; 2019."},{"key":"51_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2017.00221","volume":"4","author":"HL Zaaijer","year":"2017","unstructured":"Zaaijer HL. Prevention of transfusion-transmitted infections: dilemmas. Front Med. 2017;4:1\u20133. https:\/\/doi.org\/10.3389\/fmed.2017.00221.","journal-title":"Front Med"},{"key":"51_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/voxs.12597","volume":"15","author":"L Roman","year":"2020","unstructured":"Roman L, Armstrong B, Smart E. Donation testing and transfusion transmissible infections. ISBT Sci Ser. 2020;15:192\u2013206. https:\/\/doi.org\/10.1111\/voxs.12597.","journal-title":"ISBT Sci Ser"},{"key":"51_CR4","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jiph.2018.04.008","volume":"11","author":"M Alaidarous","year":"2018","unstructured":"Alaidarous M, Choudhary RK, Waly MI, Mir S, Bin Dukhyil A, Banawas SS, et al. The prevalence of transfusion-transmitted infections and nucleic acid testing among blood donors in Majmaah, Saudi Arabia. J Infect Public Health. 2018;11:702\u20136. https:\/\/doi.org\/10.1016\/j.jiph.2018.04.008.","journal-title":"J Infect Public Health"},{"key":"51_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-3-030-36966-8_8","volume-title":"Blood transfusion-associated infections in the twenty-first century: new challenges Current Trends and Concerns in Infectious Diseases","author":"IW Fong","year":"2020","unstructured":"Fong IW, Fong IW. Blood transfusion-associated infections in the twenty-first century: new challenges Current Trends and Concerns in Infectious Diseases. Berlin: Springer; 2020. p. 191\u2013215. https:\/\/doi.org\/10.1007\/978-3-030-36966-8_8."},{"key":"51_CR6","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1111\/trf.12371","volume":"53","author":"SL Stramer","year":"2013","unstructured":"Stramer SL, Dodd RY. Transfusion-transmitted emerging infectious diseases: 30 years of challenges and progress. Transfusion. 2013;53:2375\u201383. https:\/\/doi.org\/10.1111\/trf.12371.","journal-title":"Transfusion"},{"key":"51_CR7","first-page":"25","volume":"20","author":"OA Shobokshi","year":"2003","unstructured":"Shobokshi OA, Serebour FE, Al-Drees AZ, Mitwalli AH, Qahtani A, Skakni LI. Hepatitis C virus seroprevalence rate among Saudis. Saudi Med J. 2003;20:25.","journal-title":"Saudi Med J"},{"key":"51_CR8","unstructured":"El-Hazmi MM. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I\/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia; 2004."},{"key":"51_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4103\/1319-3767.103425","volume":"18","author":"AA Abdo","year":"2012","unstructured":"Abdo AA, Sanai FM, Al-Faleh FZ. Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook. Saudi J Gastroenterol. 2012;18:349\u201357. https:\/\/doi.org\/10.4103\/1319-3767.103425.","journal-title":"Saudi J Gastroenterol"},{"key":"51_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2019.12.004","author":"W Alabdulmonem","year":"2020","unstructured":"Alabdulmonem W, Shariq A, Alqossayir F, AbaAlkhail FM, Al-Musallam AY, Alzaaqi FO, et al. Sero-prevalence ABO and Rh blood groups and their associated transfusion-transmissible infections among blood donors in the Central Region of Saudi Arabia. J Infect Public Health. 2020. https:\/\/doi.org\/10.1016\/j.jiph.2019.12.004.","journal-title":"J Infect Public Health"},{"key":"51_CR11","first-page":"1416","volume":"30","author":"MS Bamaga","year":"2009","unstructured":"Bamaga MS, Azahar EI, Al-Ghamdi AK, Alenzi FQ, Farahat FM. Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks.[Erratum appears in Saudi Med J. 2009 Dec; 30(12):1616 Note: Al-Enzi, Faris Q [corrected to Alenzi, Faris Q]]. Saudi Med J. 2009;30:1416\u201321.","journal-title":"Saudi Med J"},{"key":"51_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4197\/Med","volume":"17","author":"WM Fageeh","year":"2010","unstructured":"Fageeh WM. Should we screen for HIV in Saudi Arabia? JKAU Med Sci. 2010;17:45\u201354. https:\/\/doi.org\/10.4197\/Med.","journal-title":"JKAU Med Sci"},{"key":"51_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4172\/2155-9864.1000280","volume":"6","author":"WM Elbjeirami","year":"2015","unstructured":"Elbjeirami WM, Arsheed NM, Al-Jedani HM, Elnagdy N, Abou Eisha HM, Abdulwahab A, et al. Prevalence and trends of HBV, HCV, and HIV serological and NAT markers and profiles in saudi blood donors. J Blood Disord Transfus. 2015;6:3. https:\/\/doi.org\/10.4172\/2155-9864.1000280.","journal-title":"J Blood Disord Transfus"},{"key":"51_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1365-2257.2004.00601.x","volume":"26","author":"LAM Bashawri","year":"2004","unstructured":"Bashawri LAM, Fawaz NA, Ahmad MS, Qadi AA, Almawi WY. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998\u20132001. Clin Lab Haematol. 2004;26:225\u20138. https:\/\/doi.org\/10.1111\/j.1365-2257.2004.00601.x.","journal-title":"Clin Lab Haematol"},{"key":"51_CR15","first-page":"1","volume":"7","author":"HA Morsi","year":"2011","unstructured":"Morsi HA. Routine use of mini-pool nucleic acid testing (MP-NAT) multiplex assay for sero-negative blood donors. J Egypt Soc Haemat Res. 2011;7:1\u20135.","journal-title":"J Egypt Soc Haemat Res"},{"key":"51_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3343\/alm.2019.39.1.81","volume":"39","author":"FM Alzahrani","year":"2018","unstructured":"Alzahrani FM, Muzaheed SSS, Alomar AI, Acharya S, Elhadi N. Prevalence of Hepatitis B Virus (HBV) among blood donors in eastern Saudi Arabia: results from a five-year retrospective study of HBV seromarkers. Ann Lab Med. 2018;39:81\u20135. https:\/\/doi.org\/10.3343\/alm.2019.39.1.81.","journal-title":"Ann Lab Med"},{"key":"51_CR17","first-page":"42","volume":"20","author":"SM Abdullah","year":"2013","unstructured":"Abdullah SM. Prevalence of hepatitis B and C in donated blood from the Jazan region of Saudi Arabia. Malays J Med Sci. 2013;20:42\u20137.","journal-title":"Malays J Med Sci"},{"key":"51_CR18","unstructured":"Committee on a National Strategy for the Elimination of Hepatitis B and C; Board on Population Health and Public Health Practice; Health and Medicine Division; National Academies of Sciences, Engineering, and Medicine; Buckley GJ, Strom BL E. Eliminating the Public Health Problem of Hepatitis B and C in the United States: phase one report. Washingt. Natl. Acad. Press, vol. June; 2016."},{"key":"51_CR19","doi-asserted-by":"crossref","unstructured":"WHO. Executive summary\u2014global hepatitis report, 2017. World Health Organ 2017.","DOI":"10.1002\/wow3.113"},{"key":"51_CR20","unstructured":"WHO. Hepatitis B 2019. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"51_CR21","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","volume":"13","author":"MJ Alter","year":"2007","unstructured":"Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007;13:2436\u201341. https:\/\/doi.org\/10.3748\/wjg.v13.i17.2436.","journal-title":"World J Gastroenterol"},{"key":"51_CR22","doi-asserted-by":"publisher","first-page":"7824","DOI":"10.3748\/wjg.v22.i34.7824","volume":"22","author":"A Petruzziello","year":"2016","unstructured":"Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016;22:7824\u201340. https:\/\/doi.org\/10.3748\/wjg.v22.i34.7824.","journal-title":"World J Gastroenterol"},{"key":"51_CR23","doi-asserted-by":"publisher","first-page":"101596","DOI":"10.1016\/j.clinre.2020.101596","volume":"45","author":"F Roudot-Thoraval","year":"2021","unstructured":"Roudot-Thoraval F. Epidemiology of hepatitis C virus infection. Clin Res Hepatol Gastroenterol. 2021;45:101596. https:\/\/doi.org\/10.1016\/j.clinre.2020.101596.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"51_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4103\/sjg.SJG_421_18","volume":"25","author":"AA Aljumah","year":"2019","unstructured":"Aljumah AA, Babatin M, Hashim A, Abaalkhail F, Bassil N, Safwat M, et al. Hepatitis B care pathway in Saudi Arabia: current situation, gaps and actions. Saudi J Gastroenterol. 2019;25:73\u201380. https:\/\/doi.org\/10.4103\/sjg.SJG_421_18.","journal-title":"Saudi J Gastroenterol"},{"key":"51_CR25","doi-asserted-by":"publisher","first-page":"474","DOI":"10.5144\/0256-4947.1988.474","volume":"8","author":"FZ Al-Faleh","year":"1998","unstructured":"Al-Faleh FZ. Hepatitis B infection in Saudi Arabia. Ann Saudi Med. 1998;8:474\u201380.","journal-title":"Ann Saudi Med"},{"key":"51_CR26","doi-asserted-by":"publisher","first-page":"e831","DOI":"10.1016\/S2352-3018(19)30196-1","volume":"6","author":"TD Frank","year":"2019","unstructured":"Frank TD, Carter A, Jahagirdar D, Biehl MH, Douwes-Schultz D, Larson SL, et al. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980\u20132017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet HIV. 2019;6:e831\u201359. https:\/\/doi.org\/10.1016\/S2352-3018(19)30196-1.","journal-title":"Lancet HIV"},{"key":"51_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2147\/IDR.S270355","volume":"14","author":"M Al-Mozaini","year":"2021","unstructured":"Al-Mozaini M, Alrahbeni T, Dirar Q, Alotibi J, Alrajhi A. HIV in the Kingdom of Saudi Arabia: can we change the way we deal with co-infections. Infect Drug Resist. 2021;14:111\u20137. https:\/\/doi.org\/10.2147\/IDR.S270355.","journal-title":"Infect Drug Resist"},{"key":"51_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/sjhs.sjhs_197_19","volume":"9","author":"T Sallam","year":"2020","unstructured":"Sallam T, El-Bingawi H, Alzahrani K, Alzahrani B, Alzahrani A. Prevalence of hepatitis B and hepatitis C viral infections and impact of control program among blood donors in Al-Baha region, Saudi Arabia. Saudi J Health Sci. 2020;9:56\u201360. https:\/\/doi.org\/10.4103\/sjhs.sjhs_197_19.","journal-title":"Saudi J Health Sci"},{"key":"51_CR29","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.15537\/smj.2016.10.14705","volume":"37","author":"AI Alshayea","year":"2016","unstructured":"Alshayea AI, Eid GE, El-Hazmi MM, Alhetheel AF. Prevalence and characterization of occult hepatitis B infection among blood donors in central Saudi Arabia. Saudi Med J. 2016;37:1114\u20139. https:\/\/doi.org\/10.15537\/smj.2016.10.14705.","journal-title":"Saudi Med J"},{"key":"51_CR30","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3855\/jidc.6666","volume":"10","author":"HH AlMutairi","year":"2016","unstructured":"AlMutairi HH, AlAhmari MM, Al-Zahran BH, Abbas IS, Al Ghamdi JAS, Raja AYA, et al. Prevalence of serological markers and nucleic acid for blood-borne viral infections in blood donors in Al-Baha, Saudi Arabia. J Infect Dev Ctries. 2016;10:619\u201325. https:\/\/doi.org\/10.3855\/jidc.6666.","journal-title":"J Infect Dev Ctries"},{"key":"51_CR31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/labmed\/lmy023","volume":"49","author":"NG Alabdallat","year":"2018","unstructured":"Alabdallat NG, Bin Dukhyil AAA. Significance of HBV NAT among HBS antigen-negative blood donors in Saudi Arabia. Lab Med. 2018;49:342\u20136. https:\/\/doi.org\/10.1093\/labmed\/lmy023.","journal-title":"Lab Med"},{"key":"51_CR32","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ijid.2008.01.010","volume":"12","author":"KE El Beltagy","year":"2008","unstructured":"El Beltagy KE, Al Balawi IA, Almuneef M, Memish ZA. Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia. Int J Infect Dis. 2008;12:495\u20139. https:\/\/doi.org\/10.1016\/j.ijid.2008.01.010.","journal-title":"Int J Infect Dis"},{"key":"51_CR33","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.18203\/2394-6040.ijcmph20184773","volume":"5","author":"JC Alcantara","year":"2018","unstructured":"Alcantara JC, Alenezi FKM, Haj Ali OH. Seroprevalence and trends of markers of transfusion transmissible infections among blood donors: a 3-year hospital based-study. Int J Community Med Public Health. 2018;5:5031. https:\/\/doi.org\/10.18203\/2394-6040.ijcmph20184773.","journal-title":"Int J Community Med Public Health"},{"issue":"6","key":"51_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S2222-1808(15)61000-3","volume":"2016","author":"Sarah YAEGA, Sabry AEGAEHES, Maryam AAS","year":"2014","unstructured":"Sarah YAEGA, Sabry AEGAEHES, Maryam AAS. Seropositivity of TTIs among blood donors in Hail, Saudi Arabia, from 2014 to 2015. Asian Pac J Trop Dis. 2014;2016(6):141\u20136. https:\/\/doi.org\/10.1016\/S2222-1808(15)61000-3.","journal-title":"Asian Pac J Trop Dis"},{"key":"51_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-6-3","volume":"6","author":"TA Madani","year":"2006","unstructured":"Madani TA. Sexually transmitted infections in Saudi Arabia. BMC Infect Dis. 2006;6:1\u20136. https:\/\/doi.org\/10.1186\/1471-2334-6-3.","journal-title":"BMC Infect Dis"},{"key":"51_CR36","first-page":"13","volume":"6","author":"EH Ibrahim","year":"2014","unstructured":"Ibrahim EH, Bin Dajem AM, Heijan AA, Hadish HF, Zahar YA, Alshehri A, Kilany MMO. Hepatitis B vaccine reduced the prevalence of antibodies to hepatitis B core antigen in blood donors in Aseer Region, Saudi Arabia, Egypt. Acad J Biol Sci. 2014;6:13\u201322.","journal-title":"Acad J Biol Sci"},{"key":"51_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4103\/JNSM.JNSM","volume":"3","author":"MF Al","year":"2020","unstructured":"Al MF. Prevalence of transfusion-transmissible infections among blood donors in Riyadh: a tertiary care hospital-based experience. J Nat Sci Med. 2020;3:247\u201351. https:\/\/doi.org\/10.4103\/JNSM.JNSM.","journal-title":"J Nat Sci Med"}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-022-00051-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-022-00051-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-022-00051-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T11:52:26Z","timestamp":1664970746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-022-00051-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["51"],"URL":"https:\/\/doi.org\/10.1007\/s44197-022-00051-7","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]},"assertion":[{"value":"28 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Authors have read the journal\u2019s policy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The current study was approved by the Jazan Health Ethics Committee, Ministry of Health. The study was conducted according to the declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}